Reaction

Product Information Content Complaint reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 203 reports · 4 co-occurring drugs

As of the last recalculation, Product Information Content Complaint appears in 203 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ABALOPARATIDE (PRR 85.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Abaloparatide2285.885.9
Oral Semaglutide2845.245.2
Apalutamide435.635.6
Guselkumab1030.130.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.